Janney Montgomery Scott’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-26,136
| Closed | -$821K | – | 3183 |
|
|
2026
Q2 | $821K | Sell |
26,136
-936
| -3% | -$27.6K | ﹤0.01% | 2039 |
|
|
2026
Q1 | $670K | Sell |
27,072
-45,385
| -63% | -$1.08M | ﹤0.01% | 1882 |
|
|
2025
Q4 | $1.69M | Buy |
72,457
+48,585
| +204% | +$1.08M | ﹤0.01% | 1436 |
|
|
2025
Q3 | $470K | Buy |
23,872
+3,542
| +17% | +$72.8K | ﹤0.01% | 2184 |
|
|
2025
Q2 | $441K | Buy |
20,330
+76
| +0.4% | +$1.79K | ﹤0.01% | 2089 |
|
|
2025
Q1 | $491K | Sell |
20,254
-3,075
| -13% | -$69.2K | ﹤0.01% | 1994 |
|
|
2024
Q4 | $487K | Buy |
23,329
+407
| +2% | +$8.74K | ﹤0.01% | 2016 |
|
|
2024
Q3 | $456K | Hold |
22,922
| – | – | ﹤0.01% | 2034 |
|
|
2024
Q2 | $355K | Buy |
22,922
+75
| +0.3% | +$1.17K | ﹤0.01% | 2117 |
|
|
2024
Q1 | $364K | Buy |
22,847
+37
| +0.2% | +$558 | ﹤0.01% | 2208 |
|
|
2023
Q4 | $383K | Sell |
22,810
-850
| -4% | -$11.6K | ﹤0.01% | 2082 |
|
|
2023
Q3 | $277K | Sell |
23,660
-462
| -2% | -$6.18K | ﹤0.01% | 2180 |
|
|
2023
Q2 | $324K | Sell |
24,122
-23,621
| -49% | -$340K | ﹤0.01% | 2177 |
|
|
2023
Q1 | $792K | Buy |
47,743
+4,939
| +12% | +$81.5K | ﹤0.01% | 1440 |
|
|
2022
Q4 | $796K | Buy |
42,804
+25,032
| +141% | +$385K | ﹤0.01% | 1488 |
|
|
2022
Q3 | $228K | Hold |
17,772
| – | – | ﹤0.01% | 2195 |
|
|
2022
Q2 | $122K | Buy |
17,772
+1,000
| +6% | +$7.34K | ﹤0.01% | 2218 |
|
|
2022
Q1 | $139K | Buy |
+16,772
| New | +$119K | ﹤0.01% | 2154 |
|
|
2014
Q4 | – | Sell |
-10,000
| Closed | -$33.2K | – | 2332 |
|
|
2014
Q3 | $33.2K | Hold |
10,000
| – | – | ﹤0.01% | 2249 |
|
|
2014
Q2 | $25.3K | Hold |
10,000
| – | – | ﹤0.01% | 2187 |
|
|
2014
Q1 | $22.6K | Hold |
10,000
| – | – | ﹤0.01% | 2015 |
|
|
2013
Q4 | $19.5K | Buy |
+10,000
| New | +$20.2K | ﹤0.01% | 1985 |
|
Other funds holding CPRX
Janney Montgomery Scott's CPRX Position: Q3 2026 in Review
Janney Montgomery Scott sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 26,136 shares — an estimated $821K sold.
Janney Montgomery Scott first reported a position in CPRX in Q4 2013 and held it in 22 quarters. The position peaked at $1.69M in Q4 2025. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.
- Janney Montgomery Scott reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Janney Montgomery Scott sold 26,136 Catalyst Pharmaceutical shares in Q3 2026, an estimated $821K.
- Janney Montgomery Scott first reported a position in Catalyst Pharmaceutical in Q4 2013 and held it in 22 quarters.
- Janney Montgomery Scott's Catalyst Pharmaceutical position peaked at $1.69M in Q4 2025.
- 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.
Based on Janney Montgomery Scott's 13F filing for Q3 2026, filed 12 Nov 2026.